Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 10/20 | 0.74 |
| ▸ | HSP90AB1 | P08238 | 10/20 | 0.74 |
| ▸ | MEN1 | O00255 | 3/20 | 0.72 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.72 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.71 |
| ▸ | HTT | P42858 | 2/20 | 0.71 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.71 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.71 |
| ▸ | TDP2 | O95551 | 1/20 | 0.71 |
| ▸ | FGB | P02675 | 1/20 | 0.71 |
| ▸ | POLB | P06746 | 1/20 | 0.71 |
| ▸ | GAA | P10253 | 1/20 | 0.71 |
| ▸ | MAPT | P10636 | 1/20 | 0.71 |
| ▸ | THRB | P10828 | 1/20 | 0.71 |
| ▸ | TSHR | P16473 | 1/20 | 0.71 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.71 |
| ▸ | RECQL | P46063 | 1/20 | 0.71 |
| ▸ | RAB9A | P51151 | 1/20 | 0.71 |
| ▸ | BLM | P54132 | 1/20 | 0.71 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pentaquine SCHEMBL29596989 | 1.00 | HSP90AA1 (0.74) | HSP90AA1HSP90AB1MEN1KMT2AALDH1A1 | |
| Pentaquine SCHEMBL6081373 | 0.94 | HSP90AA1 (0.67) | HSP90AA1HSP90AB1MEN1KMT2AALDH1A1 | |
| SCHEMBL8900580 | 0.86 | HSP90AA1 (0.98) | HSP90AA1HSP90AB1MEN1KMT2AALDH1A1 | |
| SCHEMBL8891533 | 0.86 | HSP90AA1 (0.98) | HSP90AA1HSP90AB1MEN1KMT2AALDH1A1 | |
| SCHEMBL8891243 | 0.86 | HSP90AA1 (0.98) | HSP90AA1HSP90AB1MEN1KMT2AALDH1A1 | |
| SCHEMBL8891233 | 0.86 | HSP90AA1 (0.98) | HSP90AA1HSP90AB1MEN1KMT2AALDH1A1 | |
| SCHEMBL13856507 | 0.85 | HSP90AA1 (0.80) | HSP90AA1HSP90AB1MEN1KMT2AALDH1A1 | |
| SCHEMBL18163920 | 0.85 | HSP90AA1 (0.80) | HSP90AA1HSP90AB1MEN1KMT2AALDH1A1 | |
| SCHEMBL8901953 | 0.85 | HSP90AA1 (0.71) | HSP90AA1HSP90AB1MEN1KMT2AALDH1A1 | |
| SCHEMBL8901077 | 0.85 | HSP90AA1 (0.71) | HSP90AA1HSP90AB1MEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 200 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021211923-A1 | COMPOSITIONS AND METHODS FOR TREATING DISEASE | PULMOQUINE THERAPEUTICS, INC. (US) | 2021-10-21 | — | — | WO | claimed |
| US-9016221-B2 | Surface topographies for non-toxic bioadhesion control | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2015-04-28 | — | — | US | claimed |
| US-20100226943-A1 | SURFACE TOPOGRAPHIES FOR NON-TOXIC BIOADHESION CONTROL | UNIVERSITY OF FLORIDA (US) | 2010-09-09 | — | — | US | claimed |
| US-7670631-B2 | Method for the prevention of malaria infection of humans by hepatocyte growth factor antagonists | ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda. (PT) | 2010-03-02 | — | — | US | claimed |
| EP-1954244-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | Scidose, Llc (US) | 2008-08-13 | — | — | EP | claimed |
| EP-1085086-B1 | Method for producing L-histidine by fermentation using DNA gyrase inhibitor resistant bacterial strains | KYOWA HAKKO KOGYO KK (JP) | 2008-03-19 | — | — | EP | claimed |
| EP-1829528-A2 | Aggregate with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin | IDEA AG (DE) | 2007-09-05 | — | — | EP | claimed |
| EP-1829527-A2 | Aggregate with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin | IDEA AG (DE) | 2007-09-05 | — | — | EP | claimed |
| EP-1815846-A2 | Aggregate with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin | IDEA AG (DE) | 2007-08-08 | — | — | EP | claimed |
| EP-1815847-A2 | Aggregate with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin | IDEA AG (DE) | 2007-08-08 | — | — | EP | claimed |
| EP-0743573-A2 | Method for obtaining image contrast migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| EP-0743574-A2 | Migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| US-5563014-A | SOFTENABLE LAYER CONTAINIG PHOTOSENSITIVE MARKING MATERIAL; TRANSPARENTIZING AGENT | XEROX CORPORATION (US) | 1996-10-08 | — | — | US | claimed |
| US-5514505-A | SELECTIVE TRANSPARENTIZATION OF PHOTOSENSITIVE MIGRATION MARKING PARTICLES EMBEDDED NEAR THE SURFACE OF A SOFTENABLE LAYER SUPPORTED BY AN ELECTROCONDUCTIVE SUBSTRATE | XEROX CORPORATION (US) | 1996-05-07 | — | — | US | claimed |
| EP-0473094-B1 | Process for producing L-tryptophan | KYOWA HAKKO KOGYO KK (JP) | 1995-06-21 | — | — | EP | claimed |
| EP-0473094-A2 | Process for producing L-tryptophan | KYOWA HAKKO KOGYO KABUSHIKI KAISHA (JP) | 1992-03-04 | — | — | EP | claimed |
| EP-0037175-B1 | PHARMACEUTICAL COMPOSITIONS | EFAMOL LIMITED (GB) | 1988-02-10 | — | — | EP | claimed |
| EP-0035856-B1 | PHARMACEUTICAL AND DIETARY COMPOSITIONS | EFAMOL LIMITED (GB) | 1984-07-04 | — | — | EP | claimed |
| EP-0037175-A1 | Pharmaceutical compositions | EFAMOL LIMITED (GB) | 1981-10-07 | — | — | EP | claimed |
| EP-0035856-A2 | Pharmaceutical and dietary compositions | EFAMOL LIMITED (GB) | 1981-09-16 | — | — | EP | claimed |